Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trialZijing Wang, Xu B, Fei Ma et al.|Breast Cancer Research and Treatment|2021Cited by 22